Medline Probe Cover Kits containing sterile Ultrasound Gel, Labeled as the following: a) CHP COCHLEAR SUPPLEMENT CDS, Model Number CDS983069I; b) HEAD AND NECK PACK, Model Number DYNJ30245; c) IR THYROID PACK (THLUF)642-LF, Model Number DYNJ47716B; d) CENTRAL LINE INSERTION, Model Number DYNJ63347A; e) TAVR FAIRFAX, Model Number DYNJ63634A; f) PARATHYROID PACK, Model Number DYNJ81389A; g) THYRIOD PACK, Model Number DYNJ83960; h) WMC COCHLEAR IMPLANT ADD ON, Model Number DYNJ907206D
This recall is currently active, issued July 20, 2023. It was issued by Medline Industries, Lp - Northfield.
- Recall Initiated
- May 18, 2023
- Posted
- July 20, 2023
- Recall Number
- Z-2172-2023
- Quantity
- 1861 units
- Firm Location
- Northfield, IL
- Official Source
- View on FDA website ↗
Reason for Recall
Probe covers for use during diagnostic ultrasound procedures may have an inadequate barrier at the seams.
Distribution
Worldwide Distribution: US (Nationwide) and OUS (foreign) United Arab Emirates, Singapore, Lebanon, China Qatar, Costa Rica, India, Canada, Panama & Saudi Arabia.
Lot / Code Info
all lots within expiry, distributed from Medline between December 2017 - May 2023: a) Model Number CDS983069I, UDI/DI (EA) 10195327071868, UDI/DI (CS) 40195327071869; b) Model Number DYNJ30245, UDI/DI (EA) 10080196787692, UDI/DI (CS) 40080196787693; c) Model Number DYNJ47716B, UDI/DI (EA) 10193489454536, UDI/DI (CS) 40193489454537; d) Model Number DYNJ63347A, UDI/DI (EA) 10193489278064, UDI/DI (CS) 40193489278065; e) Model Number DYNJ63634A, UDI/DI (EA) 10195327143046, UDI/DI (CS) 40195327143047; f) Model Number DYNJ81389A, UDI/DI (EA) 10195327176785, UDI/DI (CS) 40195327176786; g) Model Number DYNJ83960, UDI/DI (EA) 10195327319991, UDI/DI (CS) 40195327319992; h) Model Number DYNJ907206D, UDI/DI (EA) 10195327307011, UDI/DI (CS) 40195327307012;
Root Cause
Device Design
Action Taken
Medline distributed their recall notices to their consignees beginning on 05/18/2023 by letter. The notices explained the problem, and the risk and requested the destruction of the products. Distributors were directed to notify their consignees, have the customers document and destroy any affected product, and include your customers quantities on the response form. Beginning on 05/23/2023, Medline issued another notice to a separate group of consignees requesting that the kits be over labeled. Distributors were directed to notify the customers and have them return any affected product to the distributor for collection and return to Medline. Questions: please contact the Recall Department at 866-359-1704